KRM Ayurveda shareholders and shareholding pattern
NSE: KRMAYURVEDPharmaceuticals & Biotechnology
KRM Ayurveda Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2026 · Issue price ₹135
Last close ₹238.25up ₹8.10 (3.52%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹230.15.
28 Oct: open ₹232.00, high ₹240.50, low ₹228.05
Range of traded prices from listing on 29 Jan 2026 to 28 Oct 2026
₹156.15Low, 4 Feb 2026₹343.95High, 10 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹507 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.42
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Jan 2026
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 39,00059.0% delivered
KRM Ayurveda's shareholding pattern for Sep 2026, filed on 12 Oct 2026, with every filing from Mar 2026: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns KRM Ayurveda, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters69.30%
- Foreign institutions1.54%
- Indian institutions2.66%
- Individuals and others26.49%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Mar 2026 | Sep 2026 |
|---|---|---|
| 69.15% | 69.30% | |
| Indian promoters | 69.15% | 69.30% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 30.85% | 30.70% |
| Shares in issue | 2,12,60,800 | 2,12,60,800 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 1,62,91,800 | 1,55,20,800 |
| Promoters' shares locked in | 1,43,03,500 | 1,43,03,500 |
A dash is a line the filing did not state.
KRM Ayurveda promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is PUNEET DHAWAN, 66.91%.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| PUNEET DHAWANIndividuals and Hindu undivided families | 66.91% | 1,42,24,100 | 99.09% |
| SOM DEV DHAWANIndividuals and Hindu undivided families | 1.42% | 3,02,000 | 0.00% |
| PURNIMA MEHTAIndividuals and Hindu undivided families | 0.53% | 1,12,000 | 100.00% |
| TANYA DHAWANIndividuals and Hindu undivided families | 0.45% | 95,000 | 100.00% |
| KARUNA KHURANAIndividuals and Hindu undivided families | 0.01% | 1,400 | 100.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of KRM Ayurveda, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2026 | Sep 2026 |
|---|---|---|
| MANSI SHARE & STOCK BROKING PRIVATE LIMITEDCompanies | 1.93% | 1.42% |
| AARTH AIF GROWTH FUNDAlternative investment funds | 1.05% | 1.32% |
| CTL TRUSTEESHIP LIMITEDCompanies | – | 1.01% |
| PINE OAK GLOBAL FUNDForeign portfolio investors, category I | 2.01% | – |
| SHANNON ADVISORS PRIVATE LIMITEDCompanies | 1.07% | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Mar 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Foreign institutions: PINE OAK GLOBAL FUND no longer named, from 2.01%
- Indian institutions: AARTH AIF GROWTH FUND 1.32%, +0.27 pts
- Individuals and others: SHANNON ADVISORS PRIVATE LIMITED no longer named, from 1.07%; CTL TRUSTEESHIP LIMITED newly named at 1.01%; MANSI SHARE & STOCK BROKING PRIVATE LIMITED 1.42%, −0.51 pts